Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

cnbc.com/2025/07/31/eli-lillys-mounjaro-shows-similar-heart-health-benefits-as-trulicity.html

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers' first choice for patients with Type 2 diabetes.

This story appeared on cnbc.com, 2025-07-31 10:45:01.
The Entire Business World on a Single Page. Free to Use →